<DOC>
	<DOCNO>NCT02336516</DOCNO>
	<brief_summary>Post diarrheal hemolytic uremic syndrome ( D+HUS ) first etiology acute renal failure child less 5 year old France . Previous work highlight mortality rate 2 % prevalence renal sequela one year D+HUS onset 25 % patient D+HUS consequence gastrointestinal infection shiga toxin ( Stx ) produce E.coli ( STEC ) . The frequent straight E.coli O157H7 . The sequence STEC induce HUS well know . Typically , digestive symptom appear five day follow STEC ingestion . STEC colonize intestinal mucosa , adhere enterocyte cause typical attaching/effacing lesion inflammation . Then , diarrhea vomit occur . D+HUS occur 10 % patient consequence Stx systemic absorption . Indeed , Stx release gastrointestinal tract , transfer systemic circulation . At cellular level , Stx bind globotriosylceramide ( Gb3Cer ) localize surface endothelial epithelial cell target organ . Following bind Gb3Cer , A subunits Stx internalized trigger activation apoptotic program lead cell death . In addition , Stx also able enhance production release pro inflammatory factor ( IL-1 , TNFα , IL-6 ) . Cytokines locally produce Stx-stimulated cell amplify inflammatory process prothrombotic state lead constitution microangiopathic lesion HUS . To day , management D+HUS involve supportive care mainly base fluid management , dialysis red blood cell transfusion . Specific therapy use D+HUS ( plasma infusion , antithrombotic anti inflammatory agent ) fail improve course D+HUS . The use antibiotic remain recommended meta-analysis clearly show use bactericidal antibiotic could worse course D+HUS . In vitro experimentation highlight class antibiotic like fluoroquinolones dramatically increase production release Stx bacterial lysis worsen outcome D+HUS animal model . By contrast , azythromycin , bacteriostatic antibiotic macrolides family block protein synthesis bacteria , strong inhibitory effect Stx production release STEC well inhibit vitro growth STEC strain . In addition , azithromycin able inhibit Stx-induced production inflammatory cytokine consider essential development D+HUS . Consistently use azithromycin animal model D+HUS dramatically improve survival rate . Preliminary data human D+HUS treat azithromycin highlight low prevalence severe gastrointestinal involvement control patient . All data support hypothesis azithromycin beneficial effect D+HUS improve short long term outcome deserve formally demonstrate human D+HUS .</brief_summary>
	<brief_title>Azithromycin Post Diarrheal Haemolytic Uremic Syndrome</brief_title>
	<detailed_description>Hemolytic uremic syndrome ( HUS ) define combination microangiopathic hemolytic anemia , thrombocytopenia acute renal failure . The underlying lesion thrombotic microangiopathy ( TMA ) affect arteriole capillary wall , endothelial cell swell detachment thrombus obstruct vascular lumen . Post- diarrheal HUS ( D+HUS ) induce infection due E. coli ( STEC ) produce Shiga -like toxin ( Stx ) responsible TMA . Serotype O157 : H7 represent 63-97 % STEC causing D+HUS . Other serotypes frequently implicate outbreaks O26 : H11 , O103 : H2 , O111 : H8 , O145 : H28 ( Mariani - Kurkdjian P et al , 2001 ) ( Espié et al , 2008 ) . The D+HUS mainly affect child 3 year occur prodromal bloody diarrhea . The onset HUS surround 3 5 day onset diarrhea . D+HUS lead cause acute renal failure child 5 year ( Decludt et al . 2000 ) . In France , 100 120 pediatric case D+HUS report year . STEC infection demonstrate 85 % case . In 50 % case , one person family STEC diarrhea without HUS . The death rate acute phase 2 % 50 % D+HUS require dialysis . The predictive factor poor outcome anuria 8 day neutrophil count &gt; 20000/mm3 , severe bowel disease central nervous system ( CNS ) involvement ( Scheiring et al . 2008 ) . In 65-80 % case , seemingly ad integrum recovery renal function observe within first year D + HUS onset . However , D+HUS responsible nephron loss could lead hypertension , proteinuria chronic renal failure long term . A study perform 218 patient undergoing D+HUS chidhood , highlight presence renal sequela nearly 65 % median follow-up nearly 20 year . ( Fila et al , submit ) . Classically , human infect contaminate food ( minced meat undercooked product , unpasteurized milk cheese ... ) , animal environment ( especially cattle ) transmission person person . EHEC virulence associate presence toxin call Shigatoxins ( Stx ) presence eae gene , responsible damage attachment - clearing colon caecum . Two major type Shigatoxin , Stx1 Stx2 , many Stx1 Stx2 variant identify : three variant Stx1 least , six variant Stx2 . The determination different profile variant Stx consider predictive severity STEC infection progression HUS , especially Stx2d activate Stx2c After ingestion contaminate food , STEC able withstand acidity stomach colonize digestive tract . Toxins produce bacteria go intestinal epithelium , join circulatory system reach target organ , mainly kidneys CNS . Indeed , toxin bind specific glycolipid receptor , globotriosylceramide ( Gb3 ) surface endothelial cell target organ ( digestive tract , kidney , CNS , pancreas ) drive one hand , release pro-inflammatory factor ( TNF- α , IL6 , IL8 ) involve formation lesion microangiopathy lead apoptosis target cell ( Hurley et al . 2001 ) ( Thorpe et al , 1999 ) ( Zoja et al.2010 ) . To day , management D+HUS require supportive care . All specific therapy ( antithrombotic anti inflammatory agent , specific antibody Shigatoxin , plasma transfusion plasma exchange ) show efficacy ( Scheiring et al . 2008 ) ( Loirat et al . 2012 ) . Several retrospective prospective study suggest antibiotic increase risk HUS release Stx bacterial lysis also certain type antibiotic , increase synthesis Shiga toxin . The meta-analysis perform Wang et al use antibiotic patient STEC diarrhea D+HUS highlight increase risk develop D+HUS patient treat antibiotic ( Wang et al . 2000 ) . A second meta-analysis bring together 20 study , compare risk HUS occurrence patient STEC diarrhea treat antibiotic , conclude ( Panos et al . 2006 ) . According result , antibiotherapy actually recommended patient diarrhea EHEC patient D+HUS ( Scheiring et al . 2008 ) . However , study distinguish different class antibiotic , bring together bacteriostatic antibiotic well bactericidal . But , vitro study clearly show certain class antibiotic quinolones induce production Shigatoxin ( multiply production factor 100 ciprofloxacin ) others strong inhibitory action azithromycin ( Ohara et al . 2002 ) . Azithromycin , antibiotic macrolide family , bind 50S subunit bacterial ribosome inhibits protein synthesis block transpeptidation . This mechanism inhibit production release Shiga toxin STEC ( Ohara et al . 2002 ) . Studies animal model D+HUS ( mouse , piglet ) show drastic reduction mortality . Moreover , addition inhibitory action synthesis Stx , azithromycin modulate effect inflammatory reaction vascular endothelium induce Shigatoxin contribute thrombotic microangiopathy . Indeed , azithromycin dramatically decrease secretion IL6 , IL1 TNFα ( Gantzhorn et al . 2009 ) ( Ohara et al . 2002 ) ( Zhang Q et al . 2009 ) . Moreover , recent work Amran et al perform mouse model D+HUS highlight protective effect azithromycin occurrence neurological inhibition inflammatory mechanism induce Shigatoxin vascular endothelium brain neuron ( Amran et al . 2013 ) . On human , German outbreak D+HUS O104H4 help highlight importance early treatment azithromycin eradication carriage bacteria well eradication Stx stool ( Nitschke et al . 2012 ) . In addition , preliminary data retrospective study D+HUS Robert Debré hospital show low incidence severe digestive tract impairment patient D+HUS receive treatment azithromycin compare control group ( unpublished data ) . The objective prospective study patient D+HUS treat azithromycin prove beneficial effect renal , hematological , digestive tract neurological impairment see D+HUS reduce potential sequela .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Azotemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Patient age 6 month 18 year old , reside France , D+HUS accord definition use National Institute Public Health Surveillance ( InVS ) : Renal impairment serum creatinine &gt; 60μmol/l child less 2 year old &gt; 75μmol/l 2 year old AND hemolytic anemia define hemoglobin &lt; 10g/dl associate schizocytes ≥ 2 % Collection free inform consent holder parental authority Age &lt; 6 month &gt; 18 year . Administration antibiotics 15 day precede diagnosis D+HUS . Personal family history atypical HUS . More 15 day onset diarrhea diagnosis D+HUS . Hypersensitivity azithromycin , erythromycin , macrolide patient treat dihydroergotamine , ergotamine cisapride Severe hepatic impairment No affiliation social security scheme ( beneficiary legal ) Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>